Tegaserod
CAS No. | 145158-71-0 | Cat. No. | BCP12797 |
Name | Tegaserod | ||
Synonyms | SDZ-HTF-919; SDZ-HTF919; SDZ-HTF 919; SDZ HTF-919; SDZHTF-919; HTF919; HTF-919; HTF 919; | ||
Formula | C16H23N5O | M. Wt | 301.39 |
Description | Tegaserod is a 5-HT4 agonist for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects. Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating, and constipation associated with irritable bowel syndrome. Its use was also approved to treat chronic idiopathic constipation. | ||
Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
Targets | 5 HT Receptor/Serotonin Receptor |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.